| Literature DB >> 32429892 |
Demissie Assegu Fenta1, Kinfe Lemma2, Henok Tadele3, Birkneh Tilahun Tadesse3, Birrie Derese4.
Abstract
BACKGROUND: Bacterial meningitis is a serious inflammation of the meninges. Antimicrobial therapy on early cerebrospinal fluid (CSF) examination has an important role in diagnosis. The disease is still challenging in developing countries because of poor (diagnostic set-up, socioeconomic conditions, management), and misuse of antimicrobial therapy results in emerging antimicrobial-resistant strains. Therefore, this hospital based cross sectional study was aimed to assess the antimicrobial sensitivity profile and bacterial isolates among patients suspected of pyogenic meningitis at Hawassa University Hospital from February 2017 to 2018.Entities:
Keywords: Antimicrobial sensitivity; Bacterial isolates; Culture; Ethiopia; Hawassa; Pyogenic meningitis
Mesh:
Substances:
Year: 2020 PMID: 32429892 PMCID: PMC7238580 DOI: 10.1186/s12866-020-01808-5
Source DB: PubMed Journal: BMC Microbiol ISSN: 1471-2180 Impact factor: 3.605
Cerebrospinal fluid characteristics of the study participants
| Parameters | Frequency | |||
|---|---|---|---|---|
| Yes (%) | No (%) | Unknown (%) | ||
| Prior antibiotic treatment | 90 (22.8) | 304 (77.2) | – | |
| Indian ink Positive | 13 (3.4) | 381 (96.6) | – | |
| AFB positive | 20 (5.1) | 374 (94.9) | – | |
| Gram stain | 24 (6.1) | 370 (93.9) | – | |
| HIV | 20 (5.1) | 279 (70.8) | 95 (24.1) | |
| White blood cells (Median) | 682 cells/mm3 | – | – | |
| Neutrophil (Median) | 67% | – | – | |
| Lymphocyte (Median) | 33% | – | – | |
| Glucose (Median) | 42 mg/dl | 0.672 | ||
| Protein (Median) | 105 mg/dl | |||
| Hospital stay (Median days) | 7.5 days | 0.734 | ||
AFB Acid Fast Bacilli, HIV Human immunodeficiency Virus, mg milligram, dl deciliter, mm millimeter cub
Distribution of bacterial isolates by sex and age from culture-positive samples at Hawassa University, Hospital (n = 27)
| Bacterial isolate | Frequency | Patient category and isolate frequency | ||||
|---|---|---|---|---|---|---|
| Male | Female | Children (3mth-) | Adults (> 14 yrs) | |||
| 3mth-5 yrs | > 5 yrs- 14 yr | |||||
| N.meningitidis | 12 (44.4%) | 8 | 4 | 4 | 2 | 6 |
| H.influenzae | 3 (13.6%) | 2 | 1 | 0 | 1 | 2 |
| E.coli | 4 (14.8%) | 3 | 1 | 1 | 1 | 2 |
| S.pneumoniae | 5 (18.5%) | 2 | 3 | 2 | 1 | 2 |
| K.pneumoniae | 1 (3.7%) | 1 | 0 | 1 | 0 | 0 |
| 2 (11.1%) | 0 | 2 | 1 | 0 | 1 | |
| Total | 27 (100%) | |||||
E.coli Escherchia coli, N.meningitidis Nesseria meningitides, S.pneumoniae Streptococcus pneumoniae, K.pneumoniae Klebsella pneumoniae
Antibiotic susceptibility pattern of bacterial isolates from CSF in patients with bacterial meningitis, Hawassa University Hospital
| Antibiotic Susceptibility Pattern of Gram negative organisms (% resistant) | ||||||||||||
| S | I | R | S | I | R | S | I | R | S | I | R | |
| Penicillin G | – | – | Mic> 0.6012 (100%) | – | – | 3 (100%) | – | 1 (25%) | 3 (75%) | – | – | 1 (100%) |
| CAF | 1 (8.3%) | 6 (50%) | 5 (41.7%) | – | 1 (33.3%) | 2 (66.7%) | 1 (25%) | 2 (50%) | 1 (25%) | – | 1 (100%) | – |
| Co trimoxazole | 3 (25%) | 5 (41.7%) | 4 (33.3%) | 1 (33.3%) | – | 2 (66.7%) | – | 2 (50%) | 2 (50%) | – | – | 1 (100%) |
| Ciprofloxacin | 5 (41.7%) | 5 (41.7%) | 2 (16.7%) | 2 (66.7%) | – | 1 (33.3%) | 1 (25%) | 1 (25%) | 2 (50%) | – | 1 (100%) | – |
| Ceftriaxone | 4 (33.3%) | 0 | 8 (66.7%) | 2 (66.7%) | 1 (33.3%) | – | 1 (25%) | 1 (25%) | 2 (50%) | – | – | 1 (100%) |
| Cefotaxime | 5 (41.7%)) | 0 | 7 (58.3% | 2 (66.7%) | – | 1 (33.3%) | 1 (25%) | 1 (25%) | 2 (50%) | – | – | 1 (100%) |
| Gentamycin | 8 (66.7%) | 3 (25%) | 1 (8.3%) | 2 (66.7%) | 1 (33.3%) | – | 2 (50%) | 1 (25%) | 1 (25%) | 1 (100%) | – | – |
| Antibiotic Susceptibility Pattern of Gram positive organisms (% resistant) | ||||||||||||
| S | I | R | S | I | R | S | I | R | S | I | R | |
| Penicillin Mic> 0.06 | 0 | 0 | 5 (100%) | – | – | 2 (100%) | ||||||
| Amoxicillin | – | 1 (20%) | 4 (80%) | – | – | 2 (100%) | ||||||
| Ciprofloxacin | – | 4 (80%) | 1 (20%) | – | – | 2 (100%) | ||||||
| Cefotaxime | 2 (40%) | 2 (40%) | 1 (20%) | – | – | 2 (100%) | ||||||
| Ceftriaxone | 2 (40%) | 3 (60%) | – | – | 2 (100%) | – | ||||||
| Erythromycin | 2 (40%) | 0 | 0 | – | – | 2 (100%) | ||||||
| Gentamicin | 2 (40%) | 1 (20%) | 2 (40%) | – | 2 (40%) | 3 (60%) | ||||||
Vancomycin MIC(0.5-2 μg) | 5 (100%) | – | – | 2 (100%) | – | – | ||||||
| CAF | – | 2 (40%) | 3 (60%) | – | 2 (100%) | – | ||||||
S Sensitive, R Resistant, I Intermiadate, E.coli Escherchia Coli, N.meningitidis Nesseria meningitides, S.pneumoniae Streptococcus pneumoniae, K.pneumoniae Klebsellapneumoniae, Pen Penicillin, Amp Ampicillin, CAF Chloramphenicol, (0) Not done, (−) Not Sensitive, Intermiadate, resistance
Association of culture positivity and clinical characteristics with bacterial meningitis, at Hawassa University, Hospital
| Clinical characteristics | Total N(%) | Culture negative N(%) | Culture Positive N(%) | Odds ratio(95%CI) | ||
|---|---|---|---|---|---|---|
| Sex | Male | 210 (53.3) | 194 (92.4) | 16 (7.6) | 1.37 (1.3–7.02) | 0.049 |
| Female | 184 (46.7) | 173 (94.1) | 11 (5.9) | 0.074 | ||
| Age | < 5 yr | 71 (18.0) | 60 (84.5) | 11 (15.5) | – | – |
| 5- < 14 yr | 162 (41.1) | 155 (95.6) | 7 (4.4) | |||
| 14–50 | 141 (35.7) | 133 (94.0) | 8 (6.0) | |||
| > 50 years | 20 (5.2) | 19 (95.0) | 1 (5.0) | |||
| Fever | Yes | 330 (83.8) | 306 (92.7) | 24 (7.3) | 1.2 (1.35–4.0) | 0.784 |
| No | 64 (16.2) | 61 (95.3) | 3 (4.7) | |||
| Head ache | Yes | 205 (52.1) | 187 (91.2) | 18 (9.8) | 0.71 | 0.469 |
| No | 189 (47.9) | 180 (95.0) | 9 (5.0) | |||
| Neck Stiffness | Yes | 179 (45.4) | 157 (87.7) | 22 (14.0) | 1.18 (1.06–6.53) | 0.001 |
| No | 215 (54.6) | 210 (97.7) | 5 (2.3) | |||
| Hx of seizure | Yes | 30 (7.6) | 13 (43.4) | 17 (56.6) | 1.39 (1.15–5.99) | 0.043 |
| No | 364 (92.4) | 354 (97.3) | 10 (3.3) | |||
| Duration of illness before presentation | < 3 days | 84 (21.3) | 76 (90.5) | 8 (10.5) | – | 0.137 |
| 3-7 days | 175 (44.4) | 161 (92) | 14 (8.0) | |||
| > 7 days | 135 (34.3) | 130 (96.2) | 5 (3.8) | |||
| Temp.Grade | High | 74 (18.8) | 70 (94.3) | 4 (5.7) | – | 0.543 |
| Low | 115 (29.2) | 101 (87.8) | 14 (13.8) | |||
| Normal | 205 (52) | 196 (95.6) | 9 (4.4) | |||
| Nuchal rigidity | Yes | 172 (43.6) | 151 (87.8) | 21 (13.2) | 1.26 (1.06–4.48) | 0.001* |
| No | 222 (56.3) | 216 (97.3) | 6 (2.7) | |||
| Brudniski’s Sign | Yes | 88 (22.3) | 72 (81.8) | 16 (22.2) | 2.19 (2.07–5.51) | 0.001 |
| No | 306 (77.6) | 295 (96.4) | 11 (3.6) | |||
| Kernig’s sign | Yes | 67 (17.0) | 54 (80.6) | 13 (19.4) | 1.15 (1.09–2.73) | 0.008 |
| No | 327 (82.9) | 313 (95.7) | 14 (4.3) | |||
| Glasgow coma scale | Normal | 259 (65.7) | 242 (93.0) | 17 (7.0) | – | 0.523 |
| Impairedconsciousn | 128 (32.5) | 119 (93.0) | 9 (7.0) | |||
| Coma | 7 (1.8) | 6 (85.7) | 1 (15.3) | |||
| Prehospitalantibiotic | Yes | 202 (51.3) | 194 (96.0) | 8 (4.0) | 0.54 (0.211.39) | 0.198 |
| No | 192 (48.7) | 173 (90.0) | 19 (10) | |||
| Inhospital preLP abc | Yes | 252 (64.0) | 246 (97.6) | 6 (2.4) | 1.16 (1.14–2.95) | 0.015 |
| No | 142 (36) | 121 (85.2) | 21 (14.8) | |||
| CSF appearance | Clear | 324 (82.2) | 321 (99.1) | 3 (0.9) | 0.000 | |
| Turbid | 47 (11.9) | 23 (95.8) | 24 (4.2) | |||
| Bloody | 23 (5.9) | 23 (100) | – | |||
| CSF cell level | < 10 | 259 (65.7) | 257 (99.2) | 2 (0.8) | – | 0.001* |
| 10–100 | 64 (16.3) | 53 (82.8) | 11 (17.2) | |||
| > 100 | 71 (17.9) | 57 (80.0) | 14 (20) | |||
| CSF pro category | < 46 | 273 (69.2) | 270 (98.8) | 3 (1.2) | 0.001* | |
| 46–100 | 71 (18.0) | 56 (78.9) | 15 (21.1) | |||
| > 100 | 50 (12.8) | 41 (82.0) | 9 (18) | |||
| CSF glucose level | < 40 | 125 (31.7) | 104 (83.2) | 21 (16.8) | 1.29 (1.11–3.77) | 0.010 |
| > 40 | 269 (68.3) | 263 (97.7) | 6 (2.3) | |||
CSF Cerebrospinal Fluid, Tem. Temperature, NO Number, abc antibiotics, CSF pro CSF protein, LP Lumbar punctur